121 related articles for article (PubMed ID: 14563422)
21. TT virus infection in patients with chronic hepatitis B or C: influence on clinical, histological and virological features.
Kao JH; Chen W; Chen PJ; Lai MY; Chen DS
J Med Virol; 2000 Apr; 60(4):387-92. PubMed ID: 10686020
[TBL] [Abstract][Full Text] [Related]
22. TT virus infection during chronic hepatitis C.
Trimoulet P; de Lédinghen V; Ekouevi D; Bernard PH; Merel P; Chêne G; Couzigou P; Fleury H
Am J Gastroenterol; 2000 Jul; 95(7):1765-9. PubMed ID: 10925982
[TBL] [Abstract][Full Text] [Related]
23. GB virus C/hepatitis G virus infection in chronic hepatitis C patients with and without interferon-alpha therapy.
Yu ML; Chuang WL; Dai CY; Chen SC; Lin ZY; Hsieh MY; Tsai JF; Wang LY; Chang WY
Antiviral Res; 2001 Dec; 52(3):241-9. PubMed ID: 11675141
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and genotypic distribution of hepatitis GB-C/HG and TT viruses in blood donors, mentally retarded children and four groups of patients in eastern Anatolia, Turkey.
Kalkan A; Ozdarendeli A; Bulut Y; Saral Y; Ozden M; Keleştimur N; Toraman ZA
Jpn J Infect Dis; 2005 Aug; 58(4):222-7. PubMed ID: 16116255
[TBL] [Abstract][Full Text] [Related]
25. High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease.
Tokita H; Murai S; Kamitsukasa H; Yagura M; Harada H; Takahashi M; Okamoto H
J Med Virol; 2002 Aug; 67(4):501-9. PubMed ID: 12115995
[TBL] [Abstract][Full Text] [Related]
26. Co-infection of SENV-D among chronic hepatitis C patients treated with combination therapy with high-dose interferon-alfa and ribavirin.
Dai CY; Chuang WL; Chang WY; Chen SC; Lee LP; Hsieh MY; Hou NJ; Lin ZY; Hsieh MY; Wang LY; Yu ML
World J Gastroenterol; 2005 Jul; 11(27):4241-5. PubMed ID: 16015698
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C virus and GB virus C/hepatitis G virus viremia in Swedish blood donors with different alanine aminotransferase levels.
Björkman P; Sundström G; Widell A
Transfusion; 1998 Apr; 38(4):378-84. PubMed ID: 9595021
[TBL] [Abstract][Full Text] [Related]
28. The serological and molecular epidemiology of GB virus C/hepatitis G virus infection in a hepatitis C and B endemic area.
Yu ML; Chuang WL; Dai CY; Lu SN; Wang JH; Huang JF; Chen SC; Lin ZY; Hsieh MY; Tsai JF; Wang LY; Chang WY
J Infect; 2001 Jan; 42(1):61-6. PubMed ID: 11243756
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of TT virus infection in patients with chronic hepatitis C.
Zein NN; Arslan M; Li H; Charlton MR; Gross JB; Poterucha JJ; Therneau TM; Kolbert CP; Persing DH
Am J Gastroenterol; 1999 Oct; 94(10):3020-7. PubMed ID: 10520863
[TBL] [Abstract][Full Text] [Related]
30. Effect of TT virus co-infection on interferon response in chronic hepatitis C patients.
Kawanaka M; Niiyama G; Mahmood S; Ifukube S; Yoshida N; Onishi H; Hanano S; Ito T; Yamada G
Liver; 2002 Aug; 22(4):351-5. PubMed ID: 12296969
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and clinical significance of GB virus type C/hepatitis G virus coinfection in patients with chronic hepatitis C undergoing antiviral therapy.
Hofer H; Aydin I; Neumueller-Guber S; Mueller C; Scherzer TM; Staufer K; Steindl-Munda P; Wrba F; Ferenci P
J Viral Hepat; 2011 Jul; 18(7):513-7. PubMed ID: 20565572
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of a novel DNA virus (TTV) among patients on maintenance hemodialysis.
Schröter M; Feucht HH; Zöllner B; Schäfer P; Laufs R
Nephron; 2001 Feb; 87(2):139-42. PubMed ID: 11244308
[TBL] [Abstract][Full Text] [Related]
33. The role of transfusion-transmitted virus in patients undergoing hemodialysis.
Valtuille R; Frankel F; Gómez F; Moretto H; Fay F; Rendo P; Lef L; Fernández J
J Clin Gastroenterol; 2002 Jan; 34(1):86-8. PubMed ID: 11743253
[TBL] [Abstract][Full Text] [Related]
34. The prevalence and clinical characteristics of coinfection of SENV-H among Taiwanese chronic hepatitis C patients with combination therapy of high-dose interferon-alfa and ribavirin.
Dai CY; Chuang WL; Chang WY; Chen SC; Lee LP; Lin ZY; Hou NJ; Hsieh MY; Wang LY; Yu ML
Antiviral Res; 2004 Oct; 64(1):47-53. PubMed ID: 15451178
[TBL] [Abstract][Full Text] [Related]
35. Relationship of TT virus infection with prevalence of hepatitis C virus infection and elevated alanine aminotransferase levels.
Watanabe H; Shinzawa H; Shao L; Saito T; Takahashi T
J Med Virol; 1999 Jul; 58(3):235-8. PubMed ID: 10447418
[TBL] [Abstract][Full Text] [Related]
36. TT virus infection among IVDUs in south western China.
Cao K; Mizokami M; Orito E; Ding X; Ge XM; Huang GY; Ueda R
Scand J Infect Dis; 1999; 31(1):21-5. PubMed ID: 10381213
[TBL] [Abstract][Full Text] [Related]
37. High prevalence and phylogenetic analysis of TT-virus infection in Mongolia.
Kato H; Mizokami M; Nakano T; Kondo Y; Dashnyam B; Oyunsuren T; Ueda R
Virus Res; 1999 Apr; 60(2):171-9. PubMed ID: 10392725
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group.
Nousbaum JB; Pol S; Nalpas B; Landais P; Berthelot P; Bréchot C
Ann Intern Med; 1995 Feb; 122(3):161-8. PubMed ID: 7810932
[TBL] [Abstract][Full Text] [Related]
39. Early acquisition of TT virus in infants: possible minor role of maternal transmission.
Lin HH; Kao JH; Lee PI; Chen DS
J Med Virol; 2002 Feb; 66(2):285-90. PubMed ID: 11782941
[TBL] [Abstract][Full Text] [Related]
40. Effects of HAART on hepatitis C, hepatitis G, and TT virus in multiply coinfected HIV-positive patients with haemophilia.
Takamatsu J; Toyoda H; Fukuda Y; Nakano I; Yokozaki S; Hayashi K; Saito H
Haemophilia; 2001 Nov; 7(6):575-81. PubMed ID: 11851756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
